Mycobacterium Avium Complex Lung Disease
📧 Sign up to get email alerts when something new happens for Mycobacterium Avium Complex Lung Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2023-06-01FDA Approved: ARIKAYCE — Supplemental Application (Insmed Incorporated)
The FDA approved a supplemental application for ARIKAYCE (amikacin liposome inhalation) submitted by Insmed Incorporated. This authorization…
-
FDA approval · 2020-03-13FDA Approved: ARIKAYCE — Supplemental Application (Insmed Incorporated)
The FDA approved a supplemental application for ARIKAYCE (amikacin liposome inhalation) to expand its label for the treatment of Mycobacteri…
-
FDA approval · 2018-09-28FDA Approved: ARIKAYCE — Original Application (Insmed Incorporated)
The FDA approved ARIKAYCE (amikacin liposome inhalation suspension) from Insmed as the original approval for treatment-refractory Mycobacter…